Extremely Virulent Strain of Klebsiella pneumoniae Reaches United States
June 15th 2018An extremely virulent (hypermucoviscous) strain of Klebsiella pneumoniae (K pneumoniae) that is resistant to carbapenem and colistin has been isolated for the first time from a patient in the United States.
Read More
American College of Rheumatology Urges Policy Reform to Protect Patients with Rheumatology Diseases
June 14th 2018In response to the Trump Administration’s drug pricing blueprint, the American College of Rheumatology issued a set of policy principles on drug prices and access to rheumatology treatment.
Read More
FDA Approves Pembrolizumab for Relapsed/Refractory PMBCL, Advanced Cervical Cancer
June 14th 2018Officials with the FDA have granted accelerated approval to pembrolizumab (Keytruda, Merck) for 2 new indications, including the treatment of refractory primary mediastinal large B-cell lymphoma (PMBCL), and recurrent metastatic cervical cancer in previously treated patients whose tumors express PD-L1.
Read More